MedPath

Yllume Capsule

Registration Number: MAL22106054NC

Approved
Approval ID

6fe737718844936a

Registration Number

MAL22106054NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

ASCORBYL PALMITATEActive
Monograph: ascorbyl palmitate
L-CYSTEINEActive
Monograph: 半胱氨酸
PUNICA GRANATUM EXTRACT (POMEGRANATE)Active
Monograph: punica granatum extract (pomegranate)
PIPER NIGRUM FRUIT EXTRACT (BLACK PEPPER)Active
Monograph: piper nigrum fruit extract (black pepper)
LYCOPERSICON ESCULENTUM (TOMATO)Active
Monograph: lycopersicon esculentum (tomato)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Yllume Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform